Dave Ricks
15 statements across 1 episodes · 8 bullish · 1 bearish · 1 people on the record · first statement Nov 11, 2025 by Dave Ricks · across every show →
On the record as a speaker too: Dave Ricks's record, appearances and statements → this page counts the times other people say the name.
Everything said about Dave Ricks, oldest first
Nov 11, 2025 bullish
Nov 11, 2025 positive
Ricks: Marketing halves medical adoption time from 16 to eight years
“And there's been studies on this of medical inventions that are not promoted... It's about a sixteen-year path to full adoption. With the medicine promoted, it's half that. We have an internal goal to half that again, to get to four years, to full whatever it …”
Nov 11, 2025
Nov 11, 2025 neutral
Ricks: Lilly has had 11 CEOs in 150 years, only one external
“We've had a 150 years of that, and I'm the 11th CEO of the company. That's one less than Pope's in that period of time. So that's, it was a special honor, actually, and it's not a lifetime appointment. I can be fired any day, but the first four were family mem…”
Nov 11, 2025 neutral
Nov 11, 2025 positive
Ricks: Healthcare systems should pay a premium for generic drug resilience
“And we probably should pay a little bit more for generics. You sometimes read about injectable generics in particular that run short. That's a more complicated manufacturing process. So if you do it cheaply, you run into more problems. We probably should pay a…”
Nov 11, 2025 bullish
Nov 11, 2025 positive
Ricks: Expensive cardiovascular trial mandates protect GLP-1 incumbents from low-cost competition
“Now, by happy accident, we are all now really pleased with, like, incretins, like our trisepetide to run them because they frequently demonstrate massive benefit. Uncardiovascular. And in some ways, it creates a barrier to entry for the next low-cost Chinese p…”
Nov 11, 2025 positive
Nov 11, 2025 neutral
Nov 11, 2025
Nov 11, 2025
Nov 11, 2025 negative
Ricks: Cardiovascular trial rules added five years to diabetes drug development
“The Evandia one, we know well, we work in diabetes, actually caused a policy change, and the policy change was you must rule out cardiovascular risk prior to market entry, and as you may know some conditions like diabetes have a more continuous variable you're…”
Nov 11, 2025 positive
Ricks: Claude and xAI beat ChatGPT for science because references check out
“I don't use that one for science actually. It's too, too horrible.
Patrick Collison: So which one do you use for science?
Dave Ricks: I tend to use either Claude or the XAI one. I find it more terse. And more, the references actually check out more often.”